Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Prosthesis Failure × Cyclophosphamide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 273 Lymphoma 248 Leukemia 203 Precursor Cell Lymphoblastic Leukemia-Lymphoma 182 Lymphoma, Non-Hodgkin 157 Leukemia, Lymphocytic, Chronic, B-Cell 153 Multiple Myeloma 150 Lymphoma, Large B-Cell, Diffuse 148 Lymphoma, Follicular 123 Leukemia, Myeloid, Acute 117 Hodgkin Disease 112 Lymphoma, Mantle-Cell 108 Burkitt Lymphoma 105 Myelodysplastic Syndromes 97 Lymphoma, Large-Cell, Immunoblastic 79 Lymphoma, B-Cell, Marginal Zone 72 Recurrence 56 Neoplasms, Plasma Cell 55 Leukemia, Myeloid, Chronic-Phase 53 Dendritic Cell Sarcoma, Interdigitating 52 Melanoma 50 Leukemia, Myeloid, Accelerated Phase 50 Myeloproliferative Disorders 46 Neuroblastoma 43 Blast Crisis 43 Neoplasms 41 Leukemia, Myelomonocytic, Chronic 41 Congenital Abnormalities 37 Lymphoma, Large-Cell, Anaplastic 36 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 35

Interventions

Radiotherapy 1 Paclitaxel 1 Doxorubicin 1 Cyclophosphamide 1 Cisplatin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01918124 2018-10-12

EC-0701

Fudan University

Phase 2 Completed

Prosthesis Failure

Data powered by HemOnc (CC BY 4.0) Colophon ⚡